Fulcrum Therapeutics (FULC) Other Non-Current Liabilities (2019 - 2025)
Historic Other Non-Current Liabilities for Fulcrum Therapeutics (FULC) over the last 6 years, with Q3 2025 value amounting to $197000.0.
- Fulcrum Therapeutics' Other Non-Current Liabilities changed 0.0% to $197000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $197000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $197000.0 for FY2024, which is 0.0% changed from last year.
- As of Q3 2025, Fulcrum Therapeutics' Other Non-Current Liabilities stood at $197000.0, which was down 0.0% from $197000.0 recorded in Q2 2025.
- Over the past 5 years, Fulcrum Therapeutics' Other Non-Current Liabilities peaked at $447000.0 during Q2 2023, and registered a low of $197000.0 during Q2 2022.
- For the 4-year period, Fulcrum Therapeutics' Other Non-Current Liabilities averaged around $223642.9, with its median value being $197000.0 (2022).
- As far as peak fluctuations go, Fulcrum Therapeutics' Other Non-Current Liabilities skyrocketed by 12690.36% in 2023, and later plummeted by 5592.84% in 2024.
- Over the past 4 years, Fulcrum Therapeutics' Other Non-Current Liabilities (Quarter) stood at $197000.0 in 2022, then changed by 0.0% to $197000.0 in 2023, then changed by 0.0% to $197000.0 in 2024, then changed by 0.0% to $197000.0 in 2025.
- Its Other Non-Current Liabilities was $197000.0 in Q3 2025, compared to $197000.0 in Q2 2025 and $197000.0 in Q1 2025.